NM_022089.4:c.2972G>A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022089.4(ATP13A2):c.2972G>A(p.Arg991Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000102 in 1,613,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_022089.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP13A2 | NM_022089.4 | c.2972G>A | p.Arg991Gln | missense_variant | Exon 26 of 29 | ENST00000326735.13 | NP_071372.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000157 AC: 39AN: 248500Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 134856
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1460868Hom.: 0 Cov.: 61 AF XY: 0.0000619 AC XY: 45AN XY: 726756
GnomAD4 genome AF: 0.000466 AC: 71AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74452
ClinVar
Submissions by phenotype
Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 Uncertain:3
- -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 991 of the ATP13A2 protein (p.Arg991Gln). This variant is present in population databases (rs145548316, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with ATP13A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 566669). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ATP13A2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
ATP13A2 NM_0022089.3 exon 26 p.Arg991Gln (c.2972G>A): This variant has not been reported in the literature but is present in 0.2% (43/23840) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/1-17313652-C-T). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Inborn genetic diseases Uncertain:1
The p.R991Q variant (also known as c.2972G>A), located in coding exon 26 of the ATP13A2 gene, results from a G to A substitution at nucleotide position 2972. The arginine at codon 991 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at